MYL Technical Analysis



MYL Technical Analysis Data
As of date:11/16/2020
MYL stock price:15.86
MYL 50 DMA:15.21
MYL 200 DMA:16.31
MYL MACD (200-50):1.10
MYL RSI:71.87
Extremely
Overbought
Overbought/Oversold RSI Range
RSI Indicator (Relative Strength Index)71.87
Extremely
Oversold

Also see:
MYL Market Cap History
MYL Shares Outstanding History
MYL YTD Return

MYL Current Stock Quote
Quotes delayed 20 minutes

Email EnvelopeFree MYL Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
MYL Stock Price Chart
Technical Analysis News

NXPI Makes Notable Cross Below Critical Moving Average
48 minutes ago


Amerisafe (AMSF) Shares Cross Above 200 DMA
48 minutes ago


First Advantage Breaks Above 200-Day Moving Average - Bullish for FA
49 minutes ago


Notable Two Hundred Day Moving Average Cross - TTD
49 minutes ago


Workday Breaks Below 200-Day Moving Average - Notable for WDAY
49 minutes ago


TaskUs Breaks Above 200-Day Moving Average - Bullish for TASK
49 minutes ago


RCKT Crosses Below Key Moving Average Level
49 minutes ago


Nuvalent (NUVL) Shares Cross Below 200 DMA
49 minutes ago


SBRA Makes Bullish Cross Above Critical Moving Average
49 minutes ago


CHMG Makes Bullish Cross Above Critical Moving Average
1 hour, 21 minutes ago


ONEQ Enters Oversold Territory
1 hour, 22 minutes ago


PDP Crowded With Sellers
1 hour, 22 minutes ago


FV Crosses Critical Technical Indicator
1 hour, 22 minutes ago


LRGE Crowded With Sellers
1 hour, 22 minutes ago


JTEK Getting Very Oversold
1 hour, 22 minutes ago


More Technical Analysis News

MYL Technical Analysis Charts
MYL Technical AnalysisMYL RSI
About Viatris Inc
Mylan is engaged in the global development, licensing, manufacture, marketing and distribution of generic, branded generic, brand-name and over-the-counter (OTC) pharmaceutical products for resale by others and active pharmaceutical ingredients (API) through three reportable segments on a geographic basis, North America, Europe and Rest of World. Co.'s API business is conducted through its subsidiary, Mylan Laboratories Limited, which is included within its Rest of World segment. Among Co.'s branded prescription products are EpiPen® Auto-Injector, Perforomist® Inhalation Solution and Dymista®. Co.'s OTC portfolio includes Cold-EEZE®, MidNite® and Vivarin®, as well as other products.

When researching a stock like Mylan NV, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from MYL Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for MYL stock — the real life supply and demand for the stock over time — and examines that data in different ways.
Featured Slideshows
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
MYL Technical Analysis Charts
MYL DMAMYL MACD
Video: Technical Analysis
Video: Technical Analysis


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
MYL Technical Analysis Peers
 

MYL Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2024, All Rights Reserved

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?
⤹


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.